Condition: Unipolar Depression · Bipolar Disorder · Sponsor: Jakub Antczak
Depressed mood is the main symptom of depression, but other symptoms like cognitive impairment, anhedonia or sleep disorders may also contribute to patients suffering and are difficult to treat. rTMS is a relatively novel treatment option, whose therapeutic potential is still investigated and optimized. The aim of this study is to assess the effect of rTMS applied over two stimulation sites on cognitive impairment, anhedonia and sleep disorders in depression.
This description comes directly from the study's public registry record.
Wojciech Korzeniowski, MD · +48 12 652 45 20 · wojciech.korzen@gmail.com
Jakub Antczak, MD · +48 12 400 25 50 · jakub.antczak@uj.edu.pl
Always discuss trial participation with your own doctor first.
| The Education of Research and Development Center, Babinski Clinical Hospital | Krakow, Poland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06363981